home / stock / rkda / rkda news


RKDA News and Press, Arcadia Biosciences Inc. From 03/31/22

Stock Information

Company Name: Arcadia Biosciences Inc.
Stock Symbol: RKDA
Market: NASDAQ
Website: arcadiabio.com

Menu

RKDA RKDA Quote RKDA Short RKDA News RKDA Articles RKDA Message Board
Get RKDA Alerts

News, Short Squeeze, Breakout and More Instantly...

RKDA - Arcadia Biosciences stock sees 25% wipeout as Q4 revenue falls ~70% Y/Y

Arcadia Biosciences (RKDA -25.1%) stock fell March 31, a day after the company reported its Q4 results, which missed analysts' estimates. Q4 total revenues declined -69.55% Y/Y to $2.17M. Net loss for Q4 was $9.28M, compared to $8.9M of income in Q4 2020. Q4 operating expenses were $15.98M, c...

RKDA - IQ, FUTU and VYNT among pre market losers

Arcadia Biosciences (RKDA) -25% on Q4 results. UiPath (PATH) -19% on Q4 results. Clarus Therapeutics (CRXT) -18% on Q4 results. Sharecare (SHCR) -15% on Q4 results. InflaRx (IFRX) -13% vilobelimab fails to show statistical significance in seve...

RKDA - Arcadia Biosciences, Inc. (RKDA) CEO Stan Jacot on Q4 2021 Results - Earnings Call Transcript

Arcadia Biosciences, Inc. (RKDA) Q4 2021 Results Conference Call March 30, 2022 04:30 PM ET Company Participants Stan Jacot - President and CEO Pam Haley - CFO Conference Call Participants Ben Klieve - Lake Street Capital Presentation Operator Good afternoon, and welcome to Arcadia Bioscience...

RKDA - Arcadia Biosciences GAAP EPS of -$0.42 misses by $0.12, revenue of $2.17M misses by $1.16M

Arcadia Biosciences press release (NASDAQ:RKDA): Q4 GAAP EPS of -$0.42 misses by $0.12. Revenue of $2.17M (-69.6% Y/Y) misses by $1.16M. Shares -21.69%. For further details see: Arcadia Biosciences GAAP EPS of -$0.42 misses by $0.12, revenue of $2.17M misses by $1.16M

RKDA - Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2021 Financial Results and Business Highlights

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2021 Financial Results and Business Highlights PR Newswire – Strong balance sheet entering 2022 – – Expanded consumer product offerings in on-trend categories –...

RKDA - Arcadia Biosciences Q4 2021 Earnings Preview

Arcadia Biosciences (NASDAQ:RKDA) is scheduled to announce Q4 earnings results on Wednesday, March 30th, after market close. The consensus EPS Estimate is -$0.28 (-131.1% Y/Y) and the consensus Revenue Estimate is $3.33M (-53.3% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward r...

RKDA - Notable earnings after Wednesday's close

AESE, AGRX, BEEM, EDAP, GNLN, ISUN, IZEA, KBNT, KMPH, NDRA, OEG, PATH, PHR, RKDA, STON, OTCQX:TLLTF, USWS, VNET For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Wednesday's close

RKDA - Dynagas LNG Partners and Fusion Fuel Green among Energy/Material gainers; Arcadia Biosciences among losers

Gainers: Dynagas LNG Partners (DLNG) +14%. Fusion Fuel Green (HTOO) +8%. Lightwave Logic (LWLG) +6%. Neenah (NP) +6%. Losers: Benson Hill (BHIL) -19%. KLX Energy Services (KLXE) -13%. Advent Technologies (ADN) -11%. Enservco (ENSV) -11%. Arcadia Biosciences (RKDA) -11%. For f...

RKDA - Hoegh LNG Partners and Tellurian among Energy/Material gainers; Huntsman among losers

Gainers: NextDecade (NEXT) +33%. Dynagas LNG Partners (DLNG) +20%. Hoegh LNG Partners (HMLP) +19%. Tellurian (TELL) +16%. Western Copper and Gold (WRN) +14%. Losers: Arcadia Biosciences (RKDA) -16%. TMC the metals company (TMC) -13%. Indonesia Energy Corporation (INDO) -12%. Huntsma...

RKDA - DLNG, MULN and OCFT among mid-day movers

Gainers: Clever Leaves Holdings (CLVR) +33%. NextDecade (NEXT) +23%. Dynagas LNG (DLNG) +23%. Clarus Therapeutics (CRXT) +23%. Amylyx (AMLX) +20%. Hoegh LNG Partners LP (HMLP) +21%. Kidpik (PIK) +19%. Agrify (AGFY) +17%. NexImmune (NEXI) +17%. Joby Aviation (JOBY) +17%. Losers: Icosavax (ICVX...

Previous 10 Next 10